| 研究报告 |
|
|
|
|
| GALNT14对人乳腺癌MCF-7细胞迁移的影响 |
| 吴琛, 田焕娜, 王媛媛, 刘芳铭, 张晓康, 李秦剑, 谢园园 |
| 河北大学生命科学学院 保定 071002 |
|
| Effect of GALNT14 on the Migration of Human Breast Cancer Cells MCF-7 |
| WU Chen, TIAN Huan-na, WANG Yuan-yuan, LIU Fang-ming, ZHANG Xiao-kang, LI Qin-jian, XIE Yuan-yuan |
| Life Science College, Hebei University, Baoding 071002, China |
引用本文:
吴琛, 田焕娜, 王媛媛, 刘芳铭, 张晓康, 李秦剑, 谢园园. GALNT14对人乳腺癌MCF-7细胞迁移的影响[J]. 中国生物工程杂志, 2012, 32(07): 8-15.
WU Chen, TIAN Huan-na, WANG Yuan-yuan, LIU Fang-ming, ZHANG Xiao-kang, LI Qin-jian, XIE Yuan-yuan. Effect of GALNT14 on the Migration of Human Breast Cancer Cells MCF-7. China Biotechnology, 2012, 32(07): 8-15.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/
或
https://manu60.magtech.com.cn/biotech/CN/Y2012/V32/I07/8
|
[1] Rottger S, White J, Wandall H, et al. Localization of three human polypeptide GalNAc-transferases in HeLa cells suggests initiation of O-linked glycosylation through out the Golgi apparatus. Cell Sci,1998,111(1):45-60.
[2] Perrine C L,Ganguli A,Wu P,et al. Glycopeptide-preferring polypeptide GalNAc transferase 10 (ppGalNAc T10),involved in mucin-type O-glycosylatian,has a unique GalNAe-O-Ser/Thr-binding site in its catalytic domain not found in ppGalNAc T1 or T2.Journal of Biological Chemistry,2009,284(30):20387-20397.
[3] Pegram M D,Borges V F,lbrahim N,et a1.Phase I dose escalation pharmacokinetic mmessment of intravenous humanized anti-MUCl antibody ASl402 in patients with advanced breast cancer.Breast Cancer Rea,2009,11(5): R73.
[4] Hollingsworth M A, Swanson B J. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer, 2004, 4(1): 45-60.
[5] Shibao K, Izumi H, Nakayama Y, et al. Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide galNAc N-acetylgalactosaminyl transferase-3 in relation to differentiation and prognosis in patients with colorectal carcinoma. Prevents. Cancer, 2002,94(7): 1939-1946.
[6] Berois N, Mazal D, Ubillos L, et al. UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 as a new immunohistochemical breast cancer marker.Cytochem, 2006, 54(3): 317-328.
[7] Park J H, Nishida te T, Kijima K, et al. Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis.Cancer Res, 2010, 70(7):2759-2769.
[8] 岳爱环, 行书丽, 唐春花, 等. N-乙酰氨基半乳糖转移酶2 对胃癌细胞SGC7901 黏附迁移能力的影响. 江苏大学学报(医学版),2008,18(3):223-226. Yue A H, Xing S L,Tang C H,et al. Polypeptide: N-acetylgalactosaminyltransferase 2’s role during adhesion and migration of gastric cancer cell SGC7901 at cell level.Journal of Jiangsu University(Medicine Edition), 2008,18(3):223-226.
[9] Wu Y M, Liu C H, Hu R H, et al. Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor.Cancer Res,2011,71(23):7270-7279.
[10] Wang H, Tachibana K, Zhang Y,et al. Cloning and characterization of a novel UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase, pp-GalNAc-T14. Biochem Biophys Res Commun, 2003, 300(3): 738-744.
[11] Wagner K W, Punnoose E A, Januario T,et al. Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL.Nature Medicine,2007, 13(9):1070-1077.
[12] Stern H M, Padilla M, Wagner K, et al. Development of immunohistochemistry assays to assess GALNT14 and FUT3/6 in clinical trials of dulanermin and drozitumab. Clin Cancer Res,2010,16(5):1587-1596.
[13] Soria JC, Márk Z, Zatloukal P, et al. Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non-Small-Cell Lung Cancer.J Clin Oncol, 2011,29(33):4442-4451.
[14] Wu, C Zou M J, Wang Y Y, et al. Prokaryotic expression, purification, and production of polyclonal antibody against human polypeptide N-acetylgalactosaminyltransferase 14.Protein Expression and Purification, 2007,56(1):1-7.
[15] Wu C, Guo X D, Wang W N, et al. UDP-N-Acetyl-D-Galactosamine: Polypeptide N-Acetylgalactosaminyltransferase-14 as a potential New Immunohistochemical Marker for Breast Cancer. BMC cancer, 2010,10:123.
[16] Hassan H, Reis C A,Bennett E P, et al. The lectin domain of UDP-N-acetyl-D-galactosamine: Polypep tide N-acetyl-galactosaminyltransferase-T4 directs its glycopep tide specificities. J Biol Chem, 2000,(49):38197-38205.
[17] Casey R C, Oegema T R, Skubitz K M, et al. Cell membrane glycosylation mediates the adhesion, migration, and invasion of ovarian carcinoma cell.Clin Exp Metastasis,2003, 20(2):143-152.
[18] Zeng Z S, Guillem J G. Unique activation of matrix metalloproteinase-9 within human liver metastasis from colorectal cancer. Br J Cancer,1998, 78(3):349-353.
[19] Reyes-Reyes M E, George M D, Roberts J D, et al. P-Selectin Activates Integrin-mediated Colon Carcinoma Cell Adhesion to Fibronectin.Exp Cell Res, 2006, 312(20):4056-4069.
[20] Ngan C Y, Yamamoto H, Seshimo I, et al. A multivariate analysis of adhesion molecules expression in assessment of colorectal cancer.J Surg Oncol, 2007,95(8):652-666.
[21] Zhang H, Meng F, Wu S, et al. Engagement of I-branching β-1, 6-N-acetylglucosaminyltransferase GCNT2 in Breast Cancer Metastasis and TGF-β signalling.Cancer Res, 2011,71(14):4846-4856.
[22] Raman J, Yu G, Cynthia L. UDP-N-Acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferases: Completion of the Family Tree.Glycobiology,2011 Dec 20.
[23] Cheng L M, Kouichi T, Zhang Y,et al. Characterization of a novel human UDP-GalNAc transferase,pp-GalNAc-T10. FEBS Let,2002,531(2):115-121.
[24] 郭晓丹, 吴琛, 康现江. UDP—GalNAc:多肽N-乙酰氨基半乳糖转移酶-14.生命的化学,2010,30(1):27-32. Guo X D,Wu C,Kang X J. UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 14.Chemistry of Life, 2010, 30(1):27-32.
[25] Stetler-Stevenson W G.Type IV collagenases in tumor invasion and metastasis. Cancer M etastasis Rev,1990, 9( 4): 289-303. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
